Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

  1. Messersmith, W.A.
  2. Rajeshkumar, N.V.
  3. Aik, C.T.
  4. Xiao, F.W.
  5. Diesl, V.
  6. Choe, S.E.
  7. Follettie, M.
  8. Coughlin, C.
  9. Boschelli, F.
  10. Garcia-Garcia, E.
  11. Lopez-Rios, F.
  12. Jimeno, A.
  13. Hidalgo, M.
Aldizkaria:
Molecular Cancer Therapeutics

ISSN: 1535-7163

Argitalpen urtea: 2009

Alea: 8

Zenbakia: 6

Orrialdeak: 1484-1493

Mota: Artikulua

DOI: 10.1158/1535-7163.MCT-09-0075 GOOGLE SCHOLAR